Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective.
Saved in:
| Title: | Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective. |
|---|---|
| Authors: | Sampson MR; Division of Clinical Pharmacology 4, Office of Clinical Pharmacology, Office of Translational Sciences Division of Antiviral Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Troy SB, Belew Y, Arya V, Struble KA |
| Source: | Current opinion in HIV and AIDS [Curr Opin HIV AIDS] 2020 Jan; Vol. 15 (1), pp. 61-65. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101264945 Publication Model: Print Cited Medium: Internet ISSN: 1746-6318 (Electronic) Linking ISSN: 1746630X NLM ISO Abbreviation: Curr Opin HIV AIDS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1746-6318 |
|---|---|
| DOI: | 10.1097/COH.0000000000000587 |
